AI-driven tool streamlines multilingual pharmacovigilance literature screening.
DrugCard revolutionizes pharmacovigilance by offering AI-driven solutions for local literature screening. Designed for Contract Research Organizations (CROs), Marketing Authorization Holders (MAHs), and freelancers, it simplifies the complex task of monitoring drug safety across multiple regions and languages. Key features include AI-enabled data intelligence for comprehensive drug safety monitoring, multi-language support for screening in over 100 languages, proprietary OCR technology that delivers up to 99% accuracy, and a scalable, flexible system that adapts to new markets quickly. Users report significant time savings and high accuracy, making DrugCard a cost-effective solution for ensuring regulatory compliance and improving audit readiness.
Contact for Pricing
License: Proprietary
